Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zimmerman

Showing results (881-890 of 915) with videos related to

Pageof 92
Sort By:
Chemical Science|October 2, 2025
Breaking down per- and polyfluoroalkyl substances (PFAS): tackling multitudes of correlated electronsAlan E Rask, Lee Huntington, SungYeon Kim, et al.
Molecular Cancer Therapeutics|November 5, 2021
Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in <i>H/NRAS</i> Mutant RhabdomyosarcomaNatalia Garcia, Vanessa Del Pozo, Marielle E Yohe, et al.
Journal of Medicinal Chemistry|November 28, 2007
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptorMichael G Bell, Douglas L Gernert, Timothy A Grese, et al.
Physical Therapy|August 29, 2022
The Fibromyalgia Transcutaneous Electrical Nerve Stimulation in Physical Therapy Study Protocol: A Multisite Embedded Pragmatic TrialAndrew A Post, Dana L Dailey, Emine O Bayman, et al.
Animals : an Open Access Journal From MDPI|February 13, 2026
Use of Animal-Derived Products for Medicinal and Belief-Based Purposes in Urban Cities of Southwestern Nigeria: A One Health PerspectiveSamuel N Akpan, Ralph Buij, Frank van Langevelde, et al.
Journal of Comparative Effectiveness Research|March 12, 2026
A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano studyRichard Scott Swain, Andrew Klink, Parisa Asgarisabet, et al.
Blood|August 1, 2020
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myelomaJagoda K Jasielec, Tadeusz Kubicki, Noopur Raje, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 25, 2017
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple MyelomaErik H van Beers, Martin H van Vliet, Rowan Kuiper, et al.
Nature Communications|April 20, 2022
Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitorsKristin M Zimmerman Savill, Brian B Lee, Jason Oeh, et al.
The New England Journal of Medicine|November 2, 2012
Mumps outbreak in Orthodox Jewish communities in the United StatesAlbert E Barskey, Cynthia Schulte, Jennifer B Rosen, et al.
Pageof 92

Showing results (881-890 of 915) with videos related to

Sort By:
Pageof 92
Chemical Science|October 2, 2025
Breaking down per- and polyfluoroalkyl substances (PFAS): tackling multitudes of correlated electronsAlan E Rask, Lee Huntington, SungYeon Kim, et al.
Molecular Cancer Therapeutics|November 5, 2021
Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in <i>H/NRAS</i> Mutant RhabdomyosarcomaNatalia Garcia, Vanessa Del Pozo, Marielle E Yohe, et al.
Journal of Medicinal Chemistry|November 28, 2007
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptorMichael G Bell, Douglas L Gernert, Timothy A Grese, et al.
Physical Therapy|August 29, 2022
The Fibromyalgia Transcutaneous Electrical Nerve Stimulation in Physical Therapy Study Protocol: A Multisite Embedded Pragmatic TrialAndrew A Post, Dana L Dailey, Emine O Bayman, et al.
Animals : an Open Access Journal From MDPI|February 13, 2026
Use of Animal-Derived Products for Medicinal and Belief-Based Purposes in Urban Cities of Southwestern Nigeria: A One Health PerspectiveSamuel N Akpan, Ralph Buij, Frank van Langevelde, et al.
Journal of Comparative Effectiveness Research|March 12, 2026
A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano studyRichard Scott Swain, Andrew Klink, Parisa Asgarisabet, et al.
Blood|August 1, 2020
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myelomaJagoda K Jasielec, Tadeusz Kubicki, Noopur Raje, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 25, 2017
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple MyelomaErik H van Beers, Martin H van Vliet, Rowan Kuiper, et al.
Nature Communications|April 20, 2022
Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitorsKristin M Zimmerman Savill, Brian B Lee, Jason Oeh, et al.
The New England Journal of Medicine|November 2, 2012
Mumps outbreak in Orthodox Jewish communities in the United StatesAlbert E Barskey, Cynthia Schulte, Jennifer B Rosen, et al.
Pageof 92